Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 44.80 NOK
Change Today +3.00 / 7.18%
Volume 115.0
MEDI On Other Exchanges
Symbol
Exchange
As of 10:25 AM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

medistim asa (MEDI) Snapshot

Open
44.90 NOK
Previous Close
41.80 NOK
Day High
44.90 NOK
Day Low
44.80 NOK
52 Week High
03/12/15 - 60.00 NOK
52 Week Low
09/29/14 - 20.20 NOK
Market Cap
821.5M
Average Volume 10 Days
283.4
EPS TTM
2.03 NOK
Shares Outstanding
18.3M
EX-Date
04/24/15
P/E TM
22.1x
Dividend
1.40 NOK
Dividend Yield
3.13%
Current Stock Chart for MEDISTIM ASA (MEDI)

Related News

No related news articles were found.

medistim asa (MEDI) Related Businessweek News

No Related Businessweek News Found

medistim asa (MEDI) Details

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the Unites States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system primarily for cardiac surgery; VeriQ C, a system that combines ultrasound imaging and proven TTFM in a single system; and VeriQ that offers proven TTFM and doppler velocity measurements for intraoperative blood flow and graft patency verification. The company also provides various flow probes, such as QuickFit TTFM probes; Doppler X-Plore probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis; steam autoclavable QuickFit and Vascular TTFM probes; and PeriVascular transit time probes for measuring blood volume flow for the surgical applications, as well as offers cleaning and disinfection services for flow probes. In addition, it offers L15 high-frequency ultrasound imaging probes, which are used with MiraQ and VeriQ C devices to provide images for enhancing intraoperative quality assessment. Further, the company distributes and sells third party products. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

84 Employees
Last Reported Date: 03/8/15
Founded in 1984

medistim asa (MEDI) Top Compensated Officers

Chief Executive Officer and President
Total Annual Compensation: 2.6M NOK
Chief Financial Officer
Total Annual Compensation: 1.7M NOK
Vice President of Development
Total Annual Compensation: 1.2M NOK
Vice President of Production
Total Annual Compensation: 1.2M NOK
Vice President of Regulatory Affairs
Total Annual Compensation: 960.8K NOK
Compensation as of Fiscal Year 2014.

medistim asa (MEDI) Key Developments

Medi-Stim ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Medi-Stim ASA reported earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported sales of NOK 57,254,000 against NOK 47,868,000 a year ago. Operating results before depreciation and write offs was NOK 17,589,000 against NOK 13,743,000 a year ago. Operating result were NOK 11,740,000 against NOK 11,671,000 a year ago. Pretax profit was NOK 13,335,000 against NOK 11,922,000 a year ago. Net result was NOK 10,468,000 or NOK 0.58 per basic and diluted share against NOK 7,158,000 or NOK 0.40 per basic and diluted share a year ago. For the six months, the company reported sales of NOK 115,161,000 against NOK 96,725,000 a year ago. Operating results before depreciation and write offs was NOK 30,013,000 against NOK 23,000,000 a year ago. Operating result were NOK 21,610,000 against NOK 18,890,000 a year ago. Pretax profit was NOK 24,243,000 against NOK 19,162,000 a year ago. Net result was NOK 17,878,000 or NOK 0.99 per basic and diluted share against NOK 12,361,000 or NOK 0.68 per basic and diluted share a year ago. Cash flow from operation was NOK 13,753,000 against NOK 15,102,000 a year ago. The company had NOK 14.6 million in interest bearing debt.

Medi-Stim ASA, Q2 2015 Earnings Call, Aug 19, 2015

Medi-Stim ASA, Q2 2015 Earnings Call, Aug 19, 2015

Medistim Announces Dividend, Payable on May 5, 2015

Medistim announced that the general assembly decided a dividend of NOK 1.40 per share against NOK 0.80 per share last year. The shares are traded ex dividend the 24th of April 2015. The dividend is expected to be paid the 5th of May 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MEDI:NO 44.80 NOK +3.00

MEDI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MEDI.
View Industry Companies
 

Industry Analysis

MEDI

Industry Average

Valuation MEDI Industry Range
Price/Earnings 19.8x
Price/Sales 3.1x
Price/Book 5.5x
Price/Cash Flow 16.0x
TEV/Sales 3.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDISTIM ASA, please visit www.medistim.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.